GlaxoSmithKline in China: Challenges Faced
China is undoubtedly the largest source of income for multinational pharmaceutical enterprises, and it is also the market they attach the most importance to. This article mainly analyzes the annual report of GSK to study its development in China and the challenges it faces.
Aug 15, 2022 02:31 AM
ResearchHealthcare, Technology, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Guideline Issued by China's 17 Departments Decides to Put ART into Health Insurance
China's 17 government departments released a guideline to boost population growth on August 16. The guideline states that the Chinese government will include Assisted Reproductive Technology in health insurance.
Yesterday 04:03 PM
Gilead Reached USD 455 Mn Contract with Everest for Asian Rights
The company said it would use the money to fund additional dealmaking activities, clinical development of Calliditas Therapeutics-partnered kidney disease drug Nefecon in several Asia countries and other pipeline assets.
Aug 16, 2022 05:47 PM
A Quick Look at The Semiconductor Industry: 60 Players of Key Fields [2/2]
Aug 15, 2022 05:01 PM
WIM2022: Transcripts of Fireside Chat: China Globalization [2/2]
Aug 12, 2022 03:00 PM